• In early February 2026, Align Technology reported fourth-quarter 2025 sales of US$1,047.56 million and net income of US$135.76 million, issued 2026 revenue guidance calling for 3% to 4% worldwide growth, and confirmed completion of a US$171.57 million share repurchase program covering 1.69% of its shares.
• Alongside these results, Align expanded its collaboration with the University of Bern through Switzerland’s first large-scale oral health study, showcasing how its iTero Lumina scanner and Oral Health Suite can support population-level research and potentially deepen its integration into everyday dental care.
• Now we’ll examine how Align’s solid revenue guidance, coupled with growing international case volumes, may influence its existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Align Technology Investment Narrative Recap

To own Align, you need to believe that clear aligners and digital dental tools can keep gaining share despite macro headwinds, shifting patient mix, and pricing pressure. Near term, the key catalyst is case volume growth, especially internationally, while the biggest risk remains weaker orthodontic traffic and discounting. The latest 3% to 4% revenue growth outlook does not remove those risks, but it does signal that management is planning for measured, rather than outsized, acceleration.

The most relevant update here is Align’s 2026 revenue guidance of 3% to 4% growth, coming right after a quarter with record case volumes in Europe, Latin America, and Asia-Pacific. For investors, that pairing of modest guidance with stronger international uptake frames the debate: are we seeing the early stages of a healthier volume trend, or a cautious stance in the face of ongoing pressure on clear aligner pricing and scanner demand?

Yet even with healthier volumes, investors should be aware that sustained price pressure and mix shift could still...

Align Technology's narrative projects $4.5 billion revenue and $674.8 million earnings by 2028.

Uncover how Align Technology's forecasts yield a $183.87 fair value, in line with its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were expecting revenues near US$4.7 billion and earnings around US$708 million by 2028, but recent guidance and ongoing pricing pressure show how those upbeat views can differ sharply from more cautious takes and might be reconsidered as new data comes in.

Explore 8 other fair value estimates on Align Technology - why the stock might be worth 18% less than the current price!

Build Your Own Align Technology Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Align Technology research is our analysis highlighting 2 key rewards that could impact your investment decision.
• Our free Align Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Align Technology's overall financial health at a glance.

Want Some Alternatives?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.
• Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.